CN104474380B - 一种治疗乳腺增生病的中药及其制备方法 - Google Patents
一种治疗乳腺增生病的中药及其制备方法 Download PDFInfo
- Publication number
- CN104474380B CN104474380B CN201410662814.1A CN201410662814A CN104474380B CN 104474380 B CN104474380 B CN 104474380B CN 201410662814 A CN201410662814 A CN 201410662814A CN 104474380 B CN104474380 B CN 104474380B
- Authority
- CN
- China
- Prior art keywords
- grams
- prescription
- chinese medicine
- radix
- rascal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000218989 Trichosanthes Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 11
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 11
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 9
- 241001547125 Fritillaria thunbergii Species 0.000 claims abstract description 8
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 7
- 235000008113 selfheal Nutrition 0.000 claims abstract description 7
- 230000027758 ovulation cycle Effects 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 229940079593 drug Drugs 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 239000004375 Dextrin Substances 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 230000003111 delayed effect Effects 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 235000021552 granulated sugar Nutrition 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 210000005075 mammary gland Anatomy 0.000 abstract description 36
- 230000035755 proliferation Effects 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 14
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 44
- 210000000481 breast Anatomy 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 20
- 201000010099 disease Diseases 0.000 description 17
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 230000036541 health Effects 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 238000004080 punching Methods 0.000 description 8
- 230000004087 circulation Effects 0.000 description 6
- 230000002124 endocrine Effects 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 238000009102 step therapy Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 4
- 230000035568 catharsis Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000002445 nipple Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010026730 Mammary duct ectasia Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010043417 Therapeutic response unexpected Diseases 0.000 description 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000035929 gnawing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗治疗乳腺增生病的中药及其制备方法,属于药品制造技术领域。其主要技术特点是在基本组方炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、橘核15克的基础上分别增加两组原料:夏枯草15克、浙贝母10克、荔核15克、元胡15克和仙茅15克、补骨脂15克、菟丝子15克、川楝子15克,构成了组方一和组方二,在月经周期内交替服用。本发明组两种组方不可分割,中药服用方便,毒副作用很小,经过2053例乳腺增生临床试验证明:痊愈率92.79%,总有效率在98%以上,明显的提高了疗效,治愈后不复发。
Description
技术领域
本发明涉及一种治疗妇科的中药及其制备方法,具体地说是一种治疗治疗乳腺增生病的中药及其制备方法,属于药品制造技术领域。
背景技术
乳腺病中,良性肿瘤占大多数,而其中乳腺的增生性疾病约占52%,在体检中发病率更高,城市患病率高于农村。乳腺增生是一种与内分泌功能紊乱相关的疾病,本质上是一种生理增生与复旧不全所造成的乳腺结构紊乱症。育龄妇女发病率最高,临床主要表现为乳房胀痛,所扪及到的包块,以及引起的主要合并症——失眠多梦、月经紊乱、痛经、大便秘结等,严重的影响妇女工作和生活。
乳腺增生,一般预后良好,不会癌变。根据我国调查报告,仅有2-4%的癌变率,但这只是一个长期,漫长的过程。
国际医学会1998年的患者随访数据表明,轻度乳腺增生可在5-25年后发展为乳腺癌;中度乳腺增生可在3-16年后发展为乳腺癌;重度乳腺增生可在5-10年后发展为乳腺癌。
目前,治疗乳腺增生的方法很多,从材料选取上和治疗手段上区分主要有中药治疗、西药治疗、手术治疗、激素治疗、针灸治疗、理疗和外敷药膏治疗等。
西医治疗乳腺增生,可在短时间内达到缓解疼痛症状,包块缩小,但容易复发,治疗不彻底,长期服药容易产生药物依赖性,药物毒副作用比较大,临床应用受限。如激素类,维生素A、B6、谷维素等。
手术治疗乳腺增生创伤面大,治疗费用比较大,患者经济负担重,女性患者治疗后影响形体美,一般不容易接受,而且从根本上不能解决问题,手术治疗后复发率高。激素治疗乳腺增生容易导致内分泌紊乱,引起其他疾病。目前,这两种方法总体上不容易被患者接受。
目前,中药治疗乳腺增生主要有外敷中药膏和中成药两种疗法,外敷中药膏治疗乳腺增生具有消肿和止痛的作用,中成药治疗乳腺增生具有调节内分泌、利气和活血化瘀的作用,如乳块消、乳积灵等,这种中成药治疗乳腺增生只能用于内分泌的某一时段,由于治疗乳腺增生药物一成不变,脱离了中医辨证施治原则,有治疗不彻底性。
鉴于乳腺增生的发病率较高,病理比较复杂,失治和误治易产生不良后果。经过三十余年的临床摸索、总结,终于发明了一种新的治疗乳腺增生病的技术方案,这种中药治疗乳腺增生具有意想不到的治疗效果,临床实验证明是目前治疗乳腺增生比较理想的技术方案,而且治愈后很少复发。
发明内容
本发明的目的是为了解决现有治疗乳腺增生的药物单一性、片面性和不彻底性,解决了现有治疗乳腺增生药物组方一成不变的弊端,脱离了中医辨证施治原则的不足,从而提供一种新的技术方案,并明显的提高了疗效。
为了达到上述目的,本发明可通过以下技术方案来实现:
一种治疗乳腺增生病的中药,它是由下列组方一和组方二两种重量配比的原料制成的药剂:
组方一:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、橘核15克、夏枯草15克、浙贝母10克、荔核15克、元胡15克;
组方二:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、橘核15克、仙茅15克、补骨脂15克、菟丝子15克、川楝子15克。
由上述原料制成中药的剂型是药剂学上所包含的所有剂型。
一种治疗乳腺增生病的中药的制备方法,其制备成颗粒冲剂的方法和步骤是:
将生药原料按组方一:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、夏枯草、浙贝母、荔核、元胡;组方二:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、仙茅、补骨脂、菟丝子、川楝子,两组原料分别混合后加水煎煮浓缩成膏状,煎煮程度为生药:膏状=100∶14,用65%乙醇提取;然后加辅料糊精,糊精量为提取的药膏量的四倍,最后按糊精等量加白砂糖,浓缩成小颗粒,分装成一小包10克重量。
服用时间和步骤是:月经前期服用组方一;月经后期服用组方二。
本发明与现有技术相比所具有的优点是:组方有组方一、组方二两种,在一个月经周期分不同的时期分别服用,组方新颖,中药原料搭配合理,与现有技术相比,克服了现有技术治疗乳腺增生的药物组方一成变的缺点,并具有显著的治疗效果,组方一和组方二是治疗乳腺增生的一对孪生子,在治疗乳腺增生中二者不可分割。中药服用方便,毒副作用很小。经过2053例乳腺增生临床试验证明:痊愈率92.79%,总有效率在98%以上,本发明具有辩证论治的原则,治病求本,标本兼治的效果。
具体实施方式
下面通过具体实施例对本发明作进一步的详细说明。
治病机理:根据祖国医学的经络学说,肝郁气滞是乳腺增生病的病理基础,冲任失调为发病之本,气滞挟痰凝血瘀为发病之标,再结合现代医学理论。通过长期临床实践,总结出一套治疗乳腺增生有效方药和剂量,从理论依据、治疗原则、治疗方法、治疗用药四个方面全面的加以总结,完善,提出“二步疗法”概念。
1.理论依据。分二步认识推理:妇女的乳房是第二性征的重要器官之一,受内分泌的调节,她随着月经的周期变化而增生与复原交替进行,是一个动态变化性疾病。即经前期、经后期各阶段的内分泌水平不同。
2.治疗原则。分二步走:即经前治标,主要作用是软坚散结,消肿止痛;经后治本,主要作用是温补肾阳,调整冲任二脉。
3.治疗方法。分二步进行:第一步,消散包块、止痛,这是治疗增生的重要一环,即肿块不消疼痛不止;第二步,收缩病变部位已扩张的乳管,这是增生治疗是否彻底治愈的关键,即乳管不缩胀痛不消。
4.治疗用药。分二步调整:即经前软坚散结,经后温补肾阳,调整冲任二脉。
4.本发明的具体原料组方。
组方一:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15、青皮15克、炙甘草10克、夏枯草15克、浙贝母10克、橘核15克、荔核15克、元胡15克;
组方二:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、仙茅15克、补骨脂15克、菟丝子15克、川楝子15克、橘核15克。
一种治疗乳腺增生病的中药的制备方法,其制备成颗粒冲剂的方法和步骤是:
将生药原料按组方一:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、夏枯草、浙贝母、荔核、元胡;组方二:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、仙茅、补骨脂、菟丝子、川楝子,两组原料分别混合后加水煎煮浓缩成膏状,煎煮程度为生药:膏状=100∶14,用65%乙醇提取;然后加辅料糊精,糊精量为提取的药膏量的四倍,最后按糊精等量加白砂糖,浓缩成小颗粒,分装成一小包10克重量。
中药服用时间和步骤是:月经前期服用组方一;月经后期服用组方二。
本发明的产品名称是“康乳舒颗粒一号和康乳舒颗粒二号”。组方一的名称是《康乳舒颗粒一号》;组方二的名称是《康乳舒颗粒二号》。
本发明药物用量和方法如下:
以上组方一和组方二均加工成颗粒状,便于患者服用。具体临床应用时,按照“二步疗法”进行,经前期服用组方一,即《康乳舒颗粒一号》,经后期服用组方二,即《康乳舒颗粒二号》,每日二次,每次20克,即2小包,温开水化服。一个月为一疗程,一般二个疗程可治愈。
中医药治疗乳腺增生病时,要运用中医的辩证论治疗原则和方法,应遵循妇女月经变化而更方,临床才能收到满意的效果。
本发明采用“二步疗法”治疗乳腺增生病,由于解决了脱离祖国医学辨正施治原则的不足,而且发现了疾病复发的症结所在,并在长期临床实践中得到充分实验证明,切实地解决了乳腺增生病给广大患者带来的痛苦。
在组方一和组方二中,有一个共同特点,即围绕一个“气”字。足厥阴肝脉,上贯膈,布胸胁,绕乳头而行,乳头属肝,故乳房与足厥阴肝脉关系密切。肝主气,体阴而用阳,体阴者,肝为藏血之脏;用阳者,主疏泄气机。
如因肝血不足或情志不畅,肝气郁结,疏泄不及升降失司,气血失畅,脏腑功能失调则生乳病。由此可知,乳房之病多源于气而责于肝,肝郁气滞是乳病的病理基础。因而,乳病的治疗,首当治肝,当先调理气机。余听鸿在《外症医案汇编》中说:“治乳症,不出一气字,……治乳从一气字着笔,无论虚实新旧温凉攻补,各方之中挟理气疏络之品,使其乳络疏通,……自然壅者易通,结者易散,坚者易软。”逍遥散(炒柴胡当归炒白术茯苓炒白芍炙甘草)为肝郁血虚,脾失健运之症而设,治乳症首当之冲;青皮,山楂麦芽消食化积,活血化瘀,疏肝;元胡橘核荔核有疏通气滞、化痰通瘀的作用。瓜蒌、八月札均有疏肝郁、润肝燥、平肝逆、缓肝急之功效;艾叶炭温经散寒,仙灵脾有极强调节内分泌功能。甘草和中,调和诸药。故组方一和组方二均有疏肝理气,健脾和胃之功效。
组方一和组方二的不同之处在于组方一用夏枯草、浙贝母、元胡、荔核意在软坚散结,消肿止痛。意在解决“气滞挟痰凝血瘀而成癖”的疗效。组方二用仙茅、补骨脂、菟丝子意在温补肾阳,调正冲任二脉,川楝子有行气解郁之效。祖国医学认为,冲任二脉在女性的生长发育过程中最为重要,而乳房作为女性第二性征的重要器官之一,亦离不开冲任二脉的生理病理影响。冲为血海,任主胞宫,而肾气化生天癸,可激发冲任通盛,冲任下起胞宫,上连乳房,其气血促使胞宫和乳房的发育及其功能活动。又肝肾同源,肝藏血及主疏泄功能有赖于肾气的温煦资助,肾气不足,则肝失所养,肝之疏泄功能失常,肝气郁结,以致冲任失调,气滞挟痰凝血瘀而成癖。
总之,本发明中组方一和组方二在经期内的联合应用,解决了乳腺增生病的发病机理上,冲任失调为发病之本,气滞痰凝血瘀为发病之标,以此作为指导乳腺增生的治疗。
临床实验:
疗效标准:
痊愈:自觉症状完全消失,包块消散,B超/红外线扫描未见异常,随访一年未见复发。
显效:自觉症状消失,包块消散,扩张的乳管尚未恢复原位;或肿块消散,但局部压痛明显,随访一年病情稳定。
有效:自觉症状基本消失,包块缩小2/3以上并变软,随访一年病情基本稳定。
无效:治疗前后无明显变化或病情加重者。
年龄分析:
临床应用时间自2006年~2013年共收集完整病例2159例,其中泾阳汇奇公司医院1363例,秦渭诊所178例,陕西中医学院金秋门诊部231例,咸阳人福医院25例,咸阳国脉华医堂220例,咸阳众安堂国医馆36例。2159例中乳腺增生2053例,占总数的95.09%;乳腺纤维瘤64例,占总数的2.96%;乳腺导管扩张症(浆液性乳腺炎)27例,占总数的1.25%;导管内乳头状瘤15例,占总数的0.69%。
乳腺增生2053例中,女性2037例,占总数的99.22%,男性16例,占总数的0.78%。男女比例为1∶127(0.72∶99.22);年龄最小13岁,最大68岁。20岁以下14人(占0.68%);21岁-30岁659人(占32.1%);31岁-40岁948人(占46.18%);41岁-50岁394人(占19.20%);51岁以上38人(占1.84%)。育龄期妇女(21-40岁)占总数的78.28%。
临床实验结果:见表1
表1 2006年~2013年治疗乳腺增生2053例治疗效果统计表
典型病例:
1、陈XX,女,29岁,农民,泾阳县太平镇人,发病于2003年,自觉双乳胀痛,经前一周最明显,经后稍缓解,未引起重视。2004年因家庭小事生气后病情加重,经B超和红外线乳腺扫描,双乳外上象限多处有包块,后在本地西安等医院服西药、乳块消,外敷药,病情稍有缓解,疼痛减轻,停止治疗。三个月后病情加重,包块增大,疼痛明显,心烦易怒。后又服逍遥丸、乳积灵等效果不明显。2006年11月4日来泾阳汇奇公司医院就诊,查双乳外上象限多发性包块,软,活动,压痛明显,平素失眠多梦,月经不调,大便干燥4-5天一次,诊其脉弦数,舌体胖,边有齿痕,苔白厚。诊断为双乳增生(多发性块型),按“二步疗法”治疗,交替服用本发明组方一和组方二,即“康乳舒颗粒一号”和“康乳舒颗粒二号”一个疗程双乳肿块完全消散,二个疗程扩张的乳导管回缩正常,三大合并症恢复正常。随访一年未见复发。
2、刘X,女,36岁,工人,咸阳市勤俭路。双乳腺增生已13年,经多个医院针灸,外敷膏药,中成药治疗,时好时坏,本人失去治疗信心,经人介绍,于2010年12月31日,来咸阳国脉华医堂就诊,查体,双乳外上象限可触及大小不等的包块,压痛明显,活动度尚可。(以上均多次作红外扫描,钼靶拍片检查确诊)。病史多因工作累,心情不畅,焦虑不安,大便偏干,睡眠多梦,食欲下降,脉弦细略数,舌苔薄白,舌体正常,诊断为双乳增生(多发性块型)。按“二步疗法”治疗,交替服用“康乳舒颗粒一号”和“康乳舒颗粒二号”,二个疗程后,双乳肿块完全消散,唯平素双乳有压痛感,继服“康乳舒颗粒二号”一个疗程,自觉症状完全消失,合并症恢复正常,B超/红外线扫描报告未见异常,随访一年未见复发。
3、唐X,女,36岁,工人,住咸阳沈兴北路,西安上班。自述乳腺增生3年左右,开始未引起重视,后疼痛加重,在医院治疗、按摩、内服中成药效果不明显,后经人介绍来陕西中医学院金秋门诊部就诊。2010年11月12日,查体,双乳外上象限可触及散在多处包块,压痛(++),可推动,双乳头无溢液,失眠多梦,月经量少,提前一周以上,大便正常。按“二步疗法”治疗,交替服用“康乳舒颗粒一号”和“康乳舒颗粒二号”,一个疗程痊愈,后稍巩固治疗,随访一年未见复发。
Claims (4)
1.一种治疗乳腺增生病的中药,其特征是由下列组方一和组方二两种重量配比的原料制成的药剂:
组方一:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、橘核15克、夏枯草15克、浙贝母10克、荔核15克、元胡15克;
组方二:
炒柴胡15克、当归10克、炒白芍15克、炒白术15克、茯苓15克、全瓜篓15克、艾叶炭15克、仙灵脾15克、生山楂30克、炒麦芽30克、八月扎15克、青皮15克、炙甘草10克、橘核15克、仙茅15克、补骨脂15克、菟丝子15克、川楝子15克。
2.根据权利要求1所述的一种治疗乳腺增生病的中药,其特征是由上述原料制成中药的剂型是药剂学上所包含的所有剂型。
3.根据权利要求2所述的一种治疗乳腺增生病的中药的制备方法,其特征是制备成颗粒冲剂的方法和步骤是:
将生药原料按组方一:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、夏枯草、浙贝母、荔核、元胡;组方二:炒柴胡、当归、炒白芍、炒白术、茯苓、全瓜篓、艾叶炭、仙灵脾、生山楂、炒麦芽、八月扎、青皮、炙甘草、橘核、仙茅、补骨脂、菟丝子、川楝子,两组原料分别混合后加水煎煮浓缩成膏状,煎煮程度为生药∶膏状=100∶14,用65%乙醇提取;然后加辅料糊精,糊精量为提取的药膏量的四倍,最后按糊精等量加白砂糖,浓缩成小颗粒,分装成一小包10克重量。
4.根据权利要求1所述的一种治疗乳腺增生病的中药,其特征是服用时间和步骤是:月经前期服用组方一;月经后期服用组方二。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410662814.1A CN104474380B (zh) | 2014-11-04 | 2014-11-04 | 一种治疗乳腺增生病的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410662814.1A CN104474380B (zh) | 2014-11-04 | 2014-11-04 | 一种治疗乳腺增生病的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104474380A CN104474380A (zh) | 2015-04-01 |
CN104474380B true CN104474380B (zh) | 2017-10-27 |
Family
ID=52749081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410662814.1A Active CN104474380B (zh) | 2014-11-04 | 2014-11-04 | 一种治疗乳腺增生病的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474380B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103977362A (zh) * | 2014-06-05 | 2014-08-13 | 张君芳 | 治疗乳腺增生及早期乳腺癌的中药组方 |
CN105311395A (zh) * | 2015-11-30 | 2016-02-10 | 潘素荣 | 一种防治乳腺小叶增生的中药制剂及制法 |
CN106074963A (zh) * | 2016-08-08 | 2016-11-09 | 蓝国希 | 一种治疗乳腺增生的中药组合 |
CN107510052A (zh) * | 2017-08-25 | 2017-12-26 | 广西南宁华鑫糖业技术有限责任公司 | 一种缓解痛经和美容的组合产品及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1970053A (zh) * | 2006-11-30 | 2007-05-30 | 灵宝市商业医院 | 治疗乳痛症的药物 |
WO2009062338A1 (fr) * | 2007-11-14 | 2009-05-22 | Shangxian Gao | Médicament chinois lactogène destiné au traitement et à la prévention de maladies gynécologiques, procédés de préparation et utilisations de celui-ci |
CN103142854A (zh) * | 2013-03-19 | 2013-06-12 | 梁云爱 | 用于乳腺上皮内瘤变术后配合治疗的中药组合物 |
CN103432412A (zh) * | 2013-08-30 | 2013-12-11 | 宋克垣 | 一种治疗乳腺增生的药物及其制备方法 |
CN103432534A (zh) * | 2013-09-11 | 2013-12-11 | 杜雨柔 | 治疗乳腺增生的中药方剂 |
-
2014
- 2014-11-04 CN CN201410662814.1A patent/CN104474380B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1970053A (zh) * | 2006-11-30 | 2007-05-30 | 灵宝市商业医院 | 治疗乳痛症的药物 |
WO2009062338A1 (fr) * | 2007-11-14 | 2009-05-22 | Shangxian Gao | Médicament chinois lactogène destiné au traitement et à la prévention de maladies gynécologiques, procédés de préparation et utilisations de celui-ci |
CN103142854A (zh) * | 2013-03-19 | 2013-06-12 | 梁云爱 | 用于乳腺上皮内瘤变术后配合治疗的中药组合物 |
CN103432412A (zh) * | 2013-08-30 | 2013-12-11 | 宋克垣 | 一种治疗乳腺增生的药物及其制备方法 |
CN103432534A (zh) * | 2013-09-11 | 2013-12-11 | 杜雨柔 | 治疗乳腺增生的中药方剂 |
Non-Patent Citations (2)
Title |
---|
"疏肝消核方"治疗乳腺增生症43例临床观察;韩玉洁;《新中医》;19900831(第8期);第36-38页 * |
逍遥散加减治疗乳癖68例;郝淑琴;《现代中西医结合杂志》;20080510;第17卷(第14期);第2198页右栏"1.3治疗方法" * |
Also Published As
Publication number | Publication date |
---|---|
CN104474380A (zh) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526634B (zh) | 一种治疗乳腺增生病的中药制剂 | |
CN102940853B (zh) | 一种治疗乳腺增生疾病的脐膏 | |
CN101002847A (zh) | 治疗乳腺增生的药物及其制备方法 | |
CN104474380B (zh) | 一种治疗乳腺增生病的中药及其制备方法 | |
CN101897882B (zh) | 一种治疗乳腺小叶增生及囊肿的药物 | |
CN102258603B (zh) | 一种治疗浆细胞性乳腺炎的药物制剂及其制备方法 | |
CN101745047A (zh) | 一种治疗痛风病的中药组合物及制备方法 | |
CN104042692A (zh) | 一种治疗颈肩腰腿痛的熏蒸药物 | |
CN103157014A (zh) | 一种治疗肿瘤的苗药 | |
CN105434972A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN103285284B (zh) | 一种治疗老年性阴道炎的药物组合物 | |
CN102755515B (zh) | 治疗乳腺增生的中药汤剂 | |
CN105327313A (zh) | 一种具有袪痛及壮骨的中药组合物 | |
CN105233188A (zh) | 一种用于治疗肝癌的中药组合物及其用途 | |
CN102626502A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN102205067B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN101396534B (zh) | 一种治疗乳腺小叶增生的中药 | |
CN102283973B (zh) | 用于治疗良性肿瘤和减肥的中药膏药及其制备方法 | |
CN104958693A (zh) | 治疗乳腺增生的中药 | |
CN103933475A (zh) | 一种治疗乳腺纤维瘤的药物组合物及其制备方法和用途 | |
CN104721737A (zh) | 一种用于乳腺增生的外用制剂 | |
CN101244181A (zh) | 具有袪风胜湿、活血化瘀、通络止痛的骨痹症膏药及其制备方法 | |
CN104623562A (zh) | 用于治疗乳腺增生和乳腺肿瘤的药物组合物 | |
CN101152360A (zh) | 治疗乳腺癌内分泌不良反应的中药 | |
CN107617039B (zh) | 一种治疗腰椎骨质增生的中药组合物及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |